Australia's Anteris Technologies slides after rejecting SPAC's merger proposal

Anteris Technologies

15/02/2022 04:03

** Shares of medical tech co Anteris Technologies  AVR.AX 
fall as much as 8.8% to A$18.30, mark their worst intraday drop
since Nov. 26, 2021
    ** Co rejects proposal to merge with NASDAQ-listed special
purpose acquisition company Medicus Sciences Acquisition Corp
 MSAC.O   urn:newsml:reuters.com:*:nASX6SvTvz
    ** Says despite advantages, the timing of the proposal not
in shareholders or co's best interest
    ** Adds MSAC's proposal underscores "high interest" in co's
trademark cardiac device DurAVR
    ** As of last close, stock up 54.8% this year

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))